There are 68 AIM companies where the share price has fallen by 40% or more since the beginning of 2022. The worst performer is Sensyne Health (LON:SENS), which has slumped by more than 97% having run into financial difficulties. There is uncertainty about the future of the healthcare technology company so investing at this time is a gamble.
However, there are some fallers that do provide recovery potential because they have growing businesses and strong balance sheets. In the next few days, there will be articles about some of these prospects which are in a good position to bounce back ove...
